STREAMING NOW: Watch Now

Scientists edit heart muscle gene in stem cells, may be able to predict risk

In our human genome, there are many elusive g...

Posted: Jun 18, 2018 1:39 PM
Updated: Jun 18, 2018 1:39 PM

In our human genome, there are many elusive genetic variants related to medical conditions, but the impact of these variants to actually cause a disease has not been conclusively determined -- or ruled out.

In other words, the impact certain variants could have on your health remains a guessing game. But a new study involving the gene-editing tool CRISPR could change that.

Scientists use CRISPR to determine if a heart condition-related genetic variant in a patient poses real risk

"This is one of the very first proof of principles to show that concept," researcher says

The study, published in the journal Circulation on Monday, demonstrates for the first time how pairing CRISPR with induced pluripotent stem cell technology could be used to determine the risk of a genetic variant for cardiovascular disease.

Induced pluripotent stem cells are adult cells, such as skin or blood cells, that have been genetically reprogrammed to be like embryonic stem cells. In general, stem cells have the potential to develop into many different cell types in the body.

"Right now the problem is that a lot of people are getting their DNA sequenced and to their surprise it comes back as variants, after variants, after variants -- essentially a whole bunch of variants of uncertain significance -- and they don't know what that means," said Dr. Joseph Wu, professor and director of the Stanford Cardiovascular Institute at the Stanford School of Medicine, who was lead author of the study.

"Patients often ask us what do these variants of uncertain significance mean. But in reality, we don't know most of the time ourselves. So we end up having to follow the patients for the next five, 10, 20, or 30 years to see if the patient manifests the disease or not," Wu said.

"Here, we now have a way to shorten that time because we can generate patients' induced pluripotent stem cells from blood."

How do those stem cells then help predict if a variant is harmful or not? They can be differentiated into heart cells.

If the heart cells look abnormal, that probably means the variant of uncertain significance is pathogenic, meaning it's capable of causing disease.

If the heart cells look normal, that probably means the variant of uncertain significance is actually benign.

"This is one of the very first proof of principles to show that concept," Wu said.

'An important step towards precision medicine'

For the new study, researchers sequenced the DNA of 54 healthy people with no clinical history of cardiac disease and took a close look at the genes associated with hypertrophic cardiomyopathy, a heart condition characterized by thickening of the heart muscle.

Hypertrophic cardiomyopathy is thought to be the most common inherited or genetic heart disease. The condition is a common cause of sudden cardiac arrest in young people, including young athletes.

The researchers found 592 genetic variants across the 54 people. While 78% of the variants were categorized as benign, there were 17 people who each carried a variant categorized as "likely pathogenic." For four of those people, their variant was hypertrophic cardiomyopathy-related.

One study participant, carrying a hypertrophic cardiomyopathic-related variant in the gene called MYL3, also had several family members carrying the gene. The researchers noticed that these family members were asymptomatic in nature, meaning they had no irregular heartbeat and no enlarged heart muscle tissue.

So the researchers then took that knowledge and used CRISPR to turn the patient's stem cells with this MYL3 genetic variant from being heterozygous, meaning they have one normal and one recessive form of the variant, to being homozygous, so that they have two recessive forms of the variant.

Specifically, the researchers took the one study participant's blood cells, turned them into induced pluripotent stem cells, and then used CRISPR to edit those cells in a petri dish. The researchers then differentiated the edited stem cells so they would become heart muscle cells, and performed a comprehensive analysis to evaluate the variant, determining exactly how harmful the variant was or whether it was benign.

In this case, the study participant's variant was predicted to be benign.

A risk with using CRISPR is that it could introduce some unintended changes, but no off-target mutations were detected in the gene-edited cells, the researchers reported in their study.

"Much work remains to further develop stepping stones between editing cells in a dish and genome editing therapeutics that can treat patients, but studies such as this one help identify variants that are promising targets for therapeutic editing," said David Liu, core institute member of the Broad Institute and professor of chemistry and chemical biology at Harvard University, who was not involved in the study.

This gene-editing approach was found to be feasible in this one patient, but more research is needed to determine whether similar results would emerge among more patients.

"While it's very elegant, the major limitation of this work is that it took years of expensive work by a team of very talented scientists to do this for just one patient," said Dr. Kiran Musunuru, an associate professor of cardiovascular medicine at the University of Pennsylvania's Perelman School of Medicine, who was not involved in the new study but has conducted separate research involving CRISPR.

"It's an important step towards precision medicine, but going forward we will need to scale this up and be able to do this for dozens, hundreds, or even thousands of patients at a time, in a matter of weeks and much more cheaply," he said.

Time and cost are also limitations of this approach, Wu said.

"Cost-wise, it takes us probably about $10,000 and time-wise about six months," he said. Those six months would involve making the induced pluripotent stem cells, using CRISPR to edit the cells and then analyzing the differentiated heart cells.

Wu added, "but keep in mind that six months is actually still much better than the current alternative that we have, which is to tell patients that we don't know what the variant means."

The alternative would be following a patient with a variant for years, with the worrisome chance of a disease possibly developing or not developing. In either scenario, the patient as well as family members could have anxiety and stress.

Is this the future of gene editing?

William Lagor, an assistant professor of molecular physiology and biophysics at Baylor College of Medicine in Houston, called the new study "impressive."

"This addresses a major unmet need in patient care by helping determine whether your specific mutation is something to worry about," said Lagor, who was not involved in the study but has conducted separate research on CRISPR.

Then once a mutation has been identified as disease-causing, "this is an ideal platform for testing potential new drugs or gene therapy approaches in a patient-specific manner. This is truly personalized medicine," he said.

"The first therapeutic application of this technology would be to correct rare genetic diseases of the heart itself, where the potential benefit far outweighs the risk to the patient. Some of this technology already exists today, and it is now a matter of demonstrating that this can be done safely and effectively," he said.

A separate study published last year in the journal Nature showed how CRISPR could be used in human embryos to correct a pathogenic gene mutation called MYBPC3, which is associated with inherited heart conditions, including left ventricular noncompaction, familial dilated cardiomyopathy, and familial hypertrophic cardiomyopathy.

Whereas, "in this study CRISPR was used to make edits in cells outside of the body, so that the scientists could better analyze the cells, which is straightforward even if it takes a lot of effort," said Musunuru, who led a separate study in February that involved using CRISPR to lower cholesterol levels in mice, reducing their risk of heart disease.

"However, present-day forms of CRISPR technology do not work well enough in the actual heart muscle in a living being to correct a mutation for a disease like cardiomyopathy," he said. "It's possible that some future generation of gene-editing technology might be able to do the job of treating disease in the heart muscle, years or more likely decades in the future."

Indiana Coronavirus Cases

Data is updated nightly.

Confirmed Cases: 69255

Reported Deaths: 2996
CountyConfirmedDeaths
Marion15029724
Lake7139273
Elkhart463077
Allen3662158
St. Joseph320379
Hamilton2543104
Hendricks1774105
Vanderburgh176312
Cass17549
Johnson1667118
Porter120939
Tippecanoe111811
Clark110945
Madison86265
LaPorte84329
Howard82465
Kosciusko82213
Bartholomew74847
Marshall74422
Floyd71845
Monroe69530
Delaware65452
Boone64446
Dubois64312
Noble63729
Hancock62838
Jackson5544
LaGrange54610
Warrick52830
Shelby52226
Vigo50910
Grant50729
Dearborn47328
Morgan43732
Henry36418
Clinton3603
White34710
Montgomery34221
Wayne33410
Lawrence33127
Decatur31832
Harrison30022
Miami2592
Scott25210
Daviess24919
Greene24034
Putnam2338
Franklin22911
DeKalb2214
Jennings21312
Jasper2102
Gibson2024
Steuben2013
Ripley1907
Perry17212
Orange16424
Starke1647
Fayette1627
Wabash1613
Posey1600
Jefferson1522
Carroll1482
Whitley1486
Fulton1472
Knox1340
Wells1342
Huntington1193
Tipton1176
Washington1171
Spencer1123
Newton11110
Randolph1074
Clay1015
Adams822
Owen821
Jay810
Rush804
Sullivan781
Pulaski711
Brown701
Fountain642
Benton600
Blackford552
Ohio514
Parke481
Pike470
Crawford440
Switzerland430
Martin420
Vermillion420
Union330
Warren191
Unassigned0202

Ohio Coronavirus Cases

Data is updated nightly.

Confirmed Cases: 95106

Reported Deaths: 3570
CountyConfirmedDeaths
Franklin17404515
Cuyahoga12881482
Hamilton9248248
Lucas5035319
Montgomery409280
Summit3338217
Marion289644
Butler274360
Mahoning2437253
Pickaway236542
Stark1713137
Warren166935
Lorain165077
Columbiana158360
Trumbull1451105
Fairfield126427
Delaware121918
Licking115844
Clark109214
Lake105436
Wood95458
Clermont85911
Medina84833
Miami78137
Tuscarawas75614
Portage72460
Allen66742
Greene63511
Belmont59026
Richland54712
Ashtabula54445
Erie53527
Geauga53544
Mercer53513
Wayne50858
Ross4194
Huron3784
Ottawa36125
Athens3501
Sandusky34317
Darke34126
Madison33610
Hancock3332
Holmes3226
Auglaize2265
Lawrence2250
Union2221
Jefferson2103
Muskingum1991
Scioto1991
Putnam19817
Washington19822
Coshocton1856
Knox1857
Preble1722
Crawford1685
Seneca1673
Shelby1644
Morrow1602
Clinton1536
Hardin15312
Champaign1502
Fulton1411
Highland1361
Ashland1333
Defiance1324
Logan1302
Wyandot1257
Williams1243
Brown1181
Guernsey1127
Hocking1119
Carroll1105
Perry1093
Henry1081
Fayette1020
Monroe9118
Pike700
Van Wert701
Jackson680
Paulding620
Gallia581
Adams562
Vinton302
Meigs260
Harrison211
Morgan200
Noble160
Unassigned00
Fort Wayne
Few Clouds
73° wxIcon
Hi: 74° Lo: 54°
Feels Like: 73°
Angola
Scattered Clouds
72° wxIcon
Hi: 73° Lo: 54°
Feels Like: 72°
Huntington
Scattered Clouds
73° wxIcon
Hi: 72° Lo: 52°
Feels Like: 73°
Decatur
Broken Clouds
71° wxIcon
Hi: 73° Lo: 53°
Feels Like: 71°
Van Wert
Broken Clouds
70° wxIcon
Hi: 76° Lo: 51°
Feels Like: 70°
Sunny Wednesday
WFFT Radar
WFFT Temperatures
WFFT National

Community Events